ARCHIVES

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 10 No. 27 | July 6, 1984

Download PDF Visit The Full Archive

Related Articles

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

House Subcommittee Adds $30 Billion to NCI ’79 Budget

May 12, 1978

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

May 18, 1984

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983